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Shiras (head) is considered as the Utthamanga of the 
body because it is seat of Prana and the Indriyas. So 
the diseases pertaining to the Shiras should be 
treated with utmost care.[1] The diseases in which 
headache  is the prime  symptom  are  grouped  under  
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Shirorogas. Ardhavabhedaka is one type of Shiroroga 
which has been mentioned by almost all the Acharyas. 
The causes for Ardhavabhedaka are excessive intake 
of Rukshapadarthas, Adhyashana, Purvavatasevana, 
Atimaithuna  (excessive coitus), Vegadharna 
(suppressing of natural urges), Athishrama (excessive 
work) in which pain is appreciable in one half of the 
Shiras, Shanka, Bru, Kapala, and in Karna Pradesha.[2] 
The attacks of Ardhavabhedaka will be once in three 
days, once in fifteen days or once in a month as per 
classics. Ardhavabhedaka if left untreated leads to 
complications like deafness and blindness. Hence an 
early intervention is needed for Ardhavabhedaka. It 
can be correlated with migraine based on the 
similarity in etiology, pathology, symptoms. 
The headache is mainly classified into primary and 
secondary types of Headaches. Migraine is one among 
the most common complaint encountered in 
A B S T R A C T  
Background: Ardhavabhedaka is a type of Shiroroga with the cardinal feature of unilateral headache, 
which if left untreated leads to complications like blindness and hearing loss. This disease can be 
correlated to Migraine head-ache based  on the clinical manifestations. Nasya Karma and Shirodhara 
are the prime treatment modalities for Shirorogas. Objectives: To evaluate the effects of 
Nasyakarma and Shirodhara in the management of Ardhavabhedhaka. Material and Methods: 
Patients presenting with the classical features of Ardhavabhedaka and between the age group of 18 to 
60 years irrespective of sex were selected and allotted in Group A and B with 20 patients in each 
group. Group A was administered with Nasya with Prapaundarikadi Taila and Group B with Shirodhara 
with Prapaundarikadi Taila for 7 days. Result: Data was tabulated and analyzed using Student t-test, 
paired proportion test, which showed marked improvement in patients with Ardhavabhedaka in both 
the groups. Nasya and Shirodhara with Prapaundarikadi Taila is proved effective in all patients. 
According to percentage wise relief in the symptoms of Ardhavabhedaka in Group A and B, Group A 
showed comparatively better relief. Conclusion: On the basis of the results of this study, it can be 
clearly concluded that Nasya performed with Prapaundarikadi Taila provided significant relief in the 
signs and symptoms of Ardhavabhedaka than Shirodhara performed with Prapaundarikadi Taila. 
Key words: Migraine, Ardhavabhedaka, Prapaundarikadi Taila, Nasya, Shirodhara. 
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neurology practice. Migraine being a type of primary 
headache is the second most common cause of 
headache that afflicts 15% of the women and 6% of 
men. It is usually an episodic headache that is 
associated with certain features such as sensitivity to 
light, smell or movement, other features like nausea, 
vomiting.[3]  
Migraine doesn’t shorten the life, but in severe cases 
a state of chronic exhaustion may occur. Very rarely 
persistent cerebral symptoms with some irreversible 
vascular changes have occurred. The negative impact 
of migraine on quality of life, families and even work 
productivity is significant and often underated as a 
serious complication. Though migraine treatment and 
preventive strategies have greatly improved there is 
enormous gap between the treatment that is 
available and the treatment that is actually delivered 
for migraine. Therefore a better understanding of 
migraine and the development of better therapeutic 
alternatives are required. 
Ayurveda has mentioned various therapeutics in the 
management of Ardhavabedaka where Nasya Karma 
and Shirodhara both are considered as prime 
treatment modalities in all types of Shirorogas.[4] 
In Astanga Hridaya there is an indication of 
Prapaundarikadi Taila[5] for Shirashoola. By looking 
into the individual herbal constituents of 
Prapaundarikadi Taila, it appears that these 
combinations may be very effective in relieving the 
science and symptoms associated to 
Ardhavabedhaka. 
Hence the study entitled – “A Comparative clinical 
study of Nasya Karma and Shirodhara with 
Prapaundarikadi Taila in Ardhavabedhaka w.s.r. to 
Migraine” was selected with the aim to provide 
significant effect to improve the quality of life. 
OBJECTIVES OF THE STUDY 
1. To evaluate the effect of Nasya Karma with 
Prapaundarikadhi Taila in the management of 
Ardhavabhedhaka. 
2. To evaluate the effect of Shirodhara with 
Prapaundarikadhi Taila in the management of 
Ardhavabhedhaka. 
3. To compare the effects of Nasyakarma and 
Shirodhara in the management of 
Ardhavabhedhaka. 
MATERIALS AND METHODS 
Source of data 
Patients for the present study were selected from out 
patient department and in patient department of 
RAMCH & RC and from various camps conducted by 
RAMCH & RC Bangalore. 
Method of collection of data 
Patients who fulfilled the criteria for diagnosis and 
inclusion were selected for the present study 
irrespective of sex. 
Diagnostic Criteria 
According to International Headache Society 
1. At least 5 attacks fulfilling the following criteria ‘b 
to d’ 
2. Headache attacks lasting 4-72 hours. 
3. It must have at least one of the following 
symptoms 
a. Pain in one side of the head 
b. Pulsating or throbbing type of pain 
c. Pain severe enough to impair daily activities 
d. Pain intensified by exertion such as walking 
4. During attack one or more of the following 
symptoms 
a. Nausea or vomiting 
b. Photophobia or Phonophobia 
Inclusion Criteria 
▪ Patients diagnosed with Ardhavabhedaka aged 
between 18 to 50 years. 
▪ Patients with chronicity with > 3 months 
▪ Either sex 
▪ Patients fit for Nasya Karma and Shirodhara 
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Exclusion Criteria 
▪ Migraine with aura. 
▪ Severe depression or psychiatric disorders. 
▪ Sinusitis, cluster headache, trigeminal neuralgia. 
▪ Headache arising due to malignancy. 
▪ Pregnant lady, lactating mother. 
▪ Suryavartha, Ananthavata, Adhimantha 
Treatment Group 
40 patients of Ardhavabhedaka (Migraine) fulfilling 
the criteria for inclusion were randomly selected and 
divided 2 groups (Group A & Group B) of 20 patients 
each. Group A were subjected to Prapaundarikadi 
Taila Nasya once daily in the morning  for  a  period of 
seven days and Group B subjected to Shirodhara for 7 
days and evaluated after 7, 14 and 21 days. 
Assessment Criteria 
Assessment was done on the basis of improvement in 
symptoms. 
Patients were assessed with subjective parameters 
formulated for Ardhvabhedaka w.s.r. to migraine 
before and after treatment. 
Subjective Parameters 
a. Severity of pain 
b. Duration of pain 






The patients of either gender of the age 18 years and 
above fulfilling the diagnostic, inclusion and exclusion 
criteria were selected for the study. The selected 
patients were divided into 2 groups A and B with 20 
patients in each group. 20 patients were treated with 
Nasya and 20 patients were treated with Shirodhara 
for duration of 45 minutes for 7days. 
Nasya (Group A) 
Poorva Karma 
▪ Stanika Abhyanga with Murchita Tila Taila. 
▪ Swedana with Nadi Sweda on Jatrudhwa 
Pradesha 
Pradhana Karma 
▪ Prapaundarikadhi Taila is administered 
▪ Dose - 8 Bindus each nostril 
Paschath Karma 
▪ Gandhusa with Ushna Jala 
▪ Haridra Varti Dhoomapana 
▪ Laghu Ahara 
Shirodhara (Group B) 
Poorva Karma 
▪ Abhyanga to head and body with Murchita Tila 
Taila, eyes and ears covered with cotton. 
Pradhana Karma 
▪ Prapaundarikadhi Taila is poured continuously 
and slowly on the forehead of the patient with 
mild oscillation for 45 minutes. 
Paschath Karma 
▪ Oil from head removed 
▪ Eyes washed with cold water 
▪ Rest, Hot water bath 
Assessment Criteria 
▪ Effect of the therapies was assessed by the 
symptoms before and after the treatment 
▪ It was done on the basis of grading. 
Assessment criteria for Ardhavabhedaka 
1) Severity of Pain 
▪ Grade 3 = Unable to perform activities like 
walking  
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▪ Grade 2 = Disturbs the normal work 
▪ Grade 1 = Does not disturb the normal work  
▪ Grade 0 = No pain 
2) Duration of pain 
▪ Grade 3 = ˃12 hr  
▪ Grade 2 = 6 to 12 hr  
▪ Grade 1 = 4 to 6hr  
▪ Grade 0 = No pain 
3) Frequency of Attack 
▪ Grade 3 = 1-5 days 
▪ Grade 2 = 6-10 days 
▪ Grade 1 = ˃10 days  
▪ Grade 0 = Absent 
4) Nausea 
▪ Grade 3 = Present and it disturbs the normal 
work 
▪ Grade 2 = Present but does not disturb the 
normal work  
▪ Grade 1 = Occasionally 
▪ Grade 0 = No nausea 
5) Vomiting 
▪ Grade 3 = More than 6 episodes and forced to 
take medicine to stop vomiting  
▪ Grade 2 =2 to 5 episodes 
▪ Grade 1 = 1 to 2 episodes  
▪ Grade 0 = None 
6) Photophobia 
▪ Grade 3 = Unable to resist dim light  
▪ Grade 2 = Unable to resist normal light  
▪ Grade 1 = Unable to resist bright light  
▪ Grade 0 = No photophobia 
7) Vertigo 
▪ Grade 3 = Vertigo in which patient gets 
blacking  
▪ Grade 2 = Patient feels as if surrounding is 
revolving  
▪ Grade 1 = Feels giddiness 
▪ Grade 0 = No vertigo 
8) Phonophobia 
▪ Grade 3 = Irresistant to low intensity sound  
▪ Grade 2 = Unable to resist normal sound  
▪ Grade 1 = Unable to resist loud sound  
▪ Grade 0 = No Phonophobia 
Statistical Analysis 
▪ SPSS Version - 22.0 & R environment ver.3.2.2 
▪ Student t test (two tailed, independent) - to 
find the significance of study parameters. 
▪ Chi-square / Fisher exact test - to find 
significance of study parameters on 
categorical scale between two groups. 
▪ Paired proportion test - to find the 
significance of proportion in paired data. 
OBSERVATIONS AND RESULTS 
In the present study, 40 patients fulfilling the inclusion 
criteria of Ardhavabhedhaka were studied. Group A 
was treated with Nasya and Group B was treated with 
Shirodhara. 
Age: In this study, the incidence of migraine was 
found to be higher in the age group between 18-30 
years which was 57.5% and minimum was in the age 
group of 41-60 years which was 7%.  
Gender: In this study, the incidence of 
Ardhavabhedaka was found to be higher in females 
with 65% patients and 35% in males.  
Religion: In this study, the incidence of 
Ardhavabhedaka was found to be higher in Hindus 
with 85%, Christians with 2.5% and Muslims with 
12.5%.  
Education status: In this study, the incidence of 
Ardhavabhedhaka was found to be maximum in 
samples who are literates with 97%.  
Socio-Economic status: In this study the incidence of 
Ardhavabhedaka was found to be higher in samples of 
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middle class with 65% and less in samples of lower 
class with 7.5%.  
Marital status: In this study, the incidence of 
Ardhavabhedaka was found to be high in married 
samples with 55.% while in unmarried it was 45%.  
Occupation: In this study, the incidence of 
Ardhavabhedaka was found to be maximum in 
students with 40% and other professionals with 22.5% 
and in housewives with 15%.  
Family history: The observation on family history in 
the study shows maximum samples that is 77.5% had 
no history of Migraine in family while 22.5% of the 
samples had history of migraine in family.  
Chronicity of disease: The observation on chronicity 
of disease in the study show maximum chronicity of 1-
3 years with 60% of samples, 25% having 4-6 years 
and minimum of 15% having 7-10 years of chronicity.  
Prakriti: The observations in the sample in the study 
shows 40% were Vata-Kapha Prakriti, 30% were Vata-
Pitta Prakriti and 30% were Kapha-Pitta Prakriti. 
Treatment History: The observations in the sample in 
the study shows maximum samples i.e. 62.5% were 
taking anti migraine drugs, 20% were taking pain 
killers and minimum samples 17.5% had no habit of 
taking medicines. 
Nausea: 62.5% of patients had nausea as the 
associated symptom and 37.5% had no complaints of 
nausea. 
Vomiting: On observation of the symptoms 35% had 
vomiting as the associated symptoms and 65% had no 
complaints of vomiting 
Photophobia: 92.5% of the patients had photophobia 
as the associate symptoms and remaining 7.5% didn’t 
have. 
Phonophobia: 85% of the patients had photophobia 
as the associate symptoms and remaining 15% didn’t 
have. 
Effect of Nasya on Severity of Pain 
Before treatment the number of patients having 
Grade 3 of severity of pain (Threvratha of Vedhana) 
was 35% Grade 2 in 60% Grade 1 in 5% and Grade 0 in 
0% of the patients . After the 7days of Nasya Grade 3 
was not seen in any of the patients. Grade 2 was 
found in 20% Grade 1 was found in 10% and Grade 0 
was found in 70% of the patients. At 14th day of follow 
up, Grade 1 was seen in 50% and Grade 0 was seen in 
50%. While at 21st day of follow up Grade 2 was seen 
in 10% Grade 1 was seen in 55% and Grade 0 was 
seen in 35%. 





























2 12 (60%) 4 
(20%) 
0 (0%) 2 
(10%) 
-50.0% 
3 7 (35%) 0 (0%) 0 (0%) 0 (0%) -35.0% 
n=20, Group A: Improvement of 85% at 0 &1 grade is significant 
with P<0.001**, paired Proportion test 
Effect of Shirodhara on Teevrata of Vedana  
Before treatment the number of patients having 
Grade 3 of severity of pain (Threvratha of Vedhana) 
was 45% , Grade 2 in 50% ,Grade 1 in 5% and Grade 0 
in 0% of the patients . After the 7days of Shirodhara 
Grade 3 was not seen in any of the patients. Grade 2 
was found in 35%, Grade 1 was found in 25% and 
Grade 0 was found in 40% of the patients. At 14th day 
of follow up, Grade 3 was seen in 5%, Grade 2 was 
seen in 15% and Grade 1 was seen in 45% and Grade 0 
was seen in 35%. While at 21st day of follow up Grade 
2 was seen in 25%, Grade 1 was seen in 65% and 
Grade 0 was seen in 10%. 
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Table 2: Effect of Shirodhara on Teevrata of Vedana 



















2 (10%) 10.0% 











5 (25%) -25.0% 
3 9 (45%) 0 (0%) 1 (5%) 0 (0%) -45.0% 
n=20, Group B:  Improvement  of  70%  at 0 &1 grade is 
significant with P<0.001**, paired Proportion test 
Effects of Nasya on Vedana Pravritti Kala 
Before treatment the number of patients having 
Grade 3 of Duration of Attack (Vedana Pravritti Kala) 
was 35%, Grade 2 in 20%, Grade 1 in 45% and Grade 0 
in 0% of the patients. After the 7days of Nasya Grade 
3 was not seen in any of the patients. Grade 2 was 
found in 25%, Grade 1 was found in 5% and Grade 0 
was found in 70% of the patients. At 14th day of follow 
up, Grade 3 was seen in 0%, Grade 2 was seen in 5% 
and Grade 1 was seen in 50% and Grade 0 was seen in 
45%. While at 21st day of follow up Grade 2 was seen 
in 10%, Grade 1 was seen in 40% and Grade 0 was 
seen in 50%. 



























2 4 (20%) 5 
(25%) 
1(5%) 2(10%) -10.0% 
3 7 (35%) 0 (0%) 0 (0%) 0 (0%) -35.0% 
n=20, Group A: Improvement of 50.0% at 0 &1 grade is significant 
with P=0.038*, paired Proportion test 
Effect of Shirodhara on Vedana Pravritti Kala 
Before treatment the number of patients having 
Grade 3 of Duration of Attack (Vedana Pravritti Kala) 
was 45%, Grade 2 was seen in 15%, Grade 1 in 40% 
and Grade 0 in 0% of the patients . After the 7days of 
Shirodara Grade 3 was not seen in any of the patients. 
Grade 2 was found in 45%, Grade 1 was found in 15% 
and Grade 0 was found in 40% of the patients. At 14th 
day of follow up, Grade 3 was seen in 5%, Grade 2 was 
seen in 15% and Grade 1 was seen in 45% and Grade 0 
was seen in 35%. While at 21st day of follow up Grade 
3 was seen in 10%, Grade 2 was seen in 20%, Grade 1 
was seen in 60% and Grade 0 was seen in 10%. 
Table 4: Effect of Shirodhara on Vedana Pravritti 






























3 9 (45%) 0 (0%) 1 (5%) 2 
(10%) 
-35.0% 
n=20, Group B: Improvement of 30.0% at 0 &1 grade is significant 
with P=0.099+, paired Proportion test 
Effects of Nasya on Frequency of Attack 
Before treatment the number of patients having 
Grade 3 of Frequency of Attack was 30%, Grade 2 in 
25%, Grade 1 in 45% and Grade 0 in 0% of the 
patients. After the 7days of Nasya Grade 3 was not 
seen in any of the patients. Grade 2 was found in 25%, 
Grade 1 was found in 20% and Grade 0 was found in 
55% of the patients. At 14th day of follow up, Grade 3 
was seen in 0%, Grade 2 was seen in 15% and Grade 1 
was seen in 25% and Grade 0 was seen in 60%. While 
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at 21st day of follow up Grade 3 was seen in 0%, Grade 
2 was seen in 10%, Grade 1 was seen in 45% and 
Grade 0 was seen in 45%. 




































3 6 (30%) 0 (0%) 0 (0%) 0 
(0%) 
-30.0% 
n=20, Group A: Improvement of 45.0% at 0 grade is significant 
with P<0.001**, paired Proportion test 
Effects of Shirodhara on Frequency of Attack 
Before treatment the number of patients having 
Grade 3 of Frequency of Attack was 35%, Grade 2 was 
seen in 25%, Grade 1 in 40% and Grade 0 in 0% of the 
patients. After the 7days of Shirodara Grade 3 was not 
seen in any of the patients. Grade 2 was found in 40%, 
Grade 1 was found in 30% and Grade 0 was found in 
30% of the patients. At 14th day of follow up, Grade 3 
was seen in 5%, Grade 2 was seen in 15% and Grade 1 
was seen in 35% and Grade 0 was seen in 45%. While 
at 21st day of follow up Grade 3 was seen in 5%, Grade 
2 was seen in 20%, Grade 1 was seen in 60% and 
Grade 0 was seen in 15%. 
Table 6: Effects of Shirodhara on Frequency of Attack 




















3 (15%) 15.0% 







2 5(25%) 8 3 4(20%) -5.0% 
(40%) (15%) 
3 7(35%) 0(0%) 1(5%) 1(5%) -30.0% 
n=20, Group B: Improvement of 35.0% at 0 &1 grade is significant 
with P=0.067+, paired Proportion test 
Effects of Nasya on Nausea 
Before treatment the number of patients having 
Grade 3 of Nausea was seen in 30%, Grade 2 in 55%, 
Grade 1 in 15% and Grade 0 in 0% of the patients. 
After the 7days of Nasya Grade 3 was not seen in any 
of the patients. Grade 2 was found in 15%, Grade 1 
was found in 25% and Grade 0 was found in 60% of 
the patients. At 14th day of follow up, Grade 3 was 
seen in 0%, Grade 2 was seen in 0% and Grade 1 was 
seen in 45% and Grade 0 was seen in 55%. While at 
21st day of follow up Grade 3 was seen in 0%, Grade 2 
was seen in 0%, Grade 1 was seen in 50% and Grade 0 
was seen in 50%. 

























2 11 (55%) 3 
(15%) 
0 (0%) 0 (0%) -55.0% 
3 6 (30%) 0 (0%) 0 (0%) 0 (0%) -30.0% 
n=20, Group A: Improvement of 80.0% at 0 grade is significant 
with P<0.001**, paired Proportion test 
Effects of Shirodhara on Nausea 
Before treatment the number of patients having 
Grade 3 of Nausea was 30%, Grade 2 was seen in 60%, 
Grade 1 in 10% and Grade 0 in 0% of the patients. 
After the 7days of Shirodara Grade 3 was not seen in 
any of the patients. Grade 2 was found in 30%, Grade 
1 was found in 35% and Grade 0 was found in 35% of 
the patients. At 14th day of follow up, Grade 3 was 
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seen in 0%, Grade 2 was seen in 15% and Grade 1 was 
seen in 40% and Grade 0 was seen in 45%. While at 
21st day of follow up Grade 3 was seen in 0%, Grade 2 
was seen in 10%, Grade 1 was seen in 50% and Grade 
0 was seen in 40%. 











0 0(0%) 7(35%) 9(45%) 8(40%) 40.0% 
1 2(10%) 7(35%) 8(40%) 10(50%) 40.0% 
2 12(60%) 6(30%) 3(15%) 2(10%) -50.0% 
3 6(30%) 0(0%) 0(0%) 0(0%) -30.0% 
n=20, Group B: Improvement of 50.0% at 0 &1 grade is significant 
with P<0.001**, paired Proportion test. 
Effects of Nasya on Vomiting 
Before treatment the number of patients having 
Grade 3 of Vomiting was seen in 0%, Grade 2 in 40%, 
Grade 1 in 15% and Grade 0 in 9% of the patients. 
After the 7days of Nasya, Grade 3 was not seen in any 
of the patients. Grade 2 was found in 0%, Grade 1 was 
found in 25% and Grade 0 was found in 75% of the 
patients. At 14th day of follow up, Grade 3 was seen in 
0%, Grade 2 was seen in 0% and Grade 1 was seen in 
5% and Grade 0 was seen in 95%. While at 21st day of 
follow up Grade 3 was seen in 0%, Grade 2 was seen 
in 0%, Grade 1was seen in 15% and Grade 0 was seen 
in 85%. 























2 8 (40%) 0 (0%) 0(0%) 0 (0%) -40.0% 
3 0 (0%) 0 (0%) 0(0%) 0 (0%) 0.0% 
n=20, Group A: Improvement of 45% at 0 grade is significant with 
P=0.055+, paired Proportion test 
Effects of Shirodhara on Vomiting 
Before treatment the number of patients having 
Grade 3 of Vomiting was 0%, Grade 2 was seen in 
30%, Grade 1 in 30% and Grade 0 in 40% of the 
patients. After the 7days of Shirodhara Grade 3 was 
not seen in any of the patients. Grade 2 was found in 
10%, Grade 1 was found in 30% and Grade 0 was 
found in 60% of the patients. At 14th day of follow up, 
Grade 3 was seen in 0%, Grade 2 was seen in 0% and 
Grade 1 was seen in 20% and Grade 0 was seen in 
80%. While at 21st day of follow up Grade 3 was seen 
in 0%, Grade 2 was seen in 0%, Grade 1 was seen  in 
15% and Grade 0 was seen in 85%. 


























2 6 (30%) 2 
(10%) 
0 (0%) 0 (0%) -30.0% 
3 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0.0% 
n=20, Group B: Improvement of 40% at 0 grade is significant with 
P=0.032+, paired Proportion test 
Effects of Nasya on Photophobia 
Before treatment the number of patients having 
Grade 3 of Photophobia was seen in 20%, Grade 2 in 
45%, Grade 1 in 35% and Grade 0 in 0% of the 
patients. After the 7days of Nasya, Grade 3 was seen 
in 5%, Grade 2 was found in 15%, Grade 1 was found 
in 20% and Grade 0 was found in 60% of the patients. 
At 14th day of follow up, Grade 3 was seen in 0%, 
Grade 2 was seen in 0% and Grade 1 was seen in 40% 
and Grade 0 was seen in 60%. While at 21st day of 
follow up Grade 3 was seen in 0%, Grade 2 was seen 
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in 0%, Grade 1was seen in 40% and Grade 0 was seen 
in 60%. 










































n=20, Group A: Improvement of 65.0% at 0 &1 grade is significant 
with P=0.003**, paired Proportion test 
Effects of Shirodhara on Photophobia 
Before treatment the number of patients having 
Grade 3 of Photophobia was 20% , Grade 2 was seen 
in 45% ,Grade 1 in 35% and Grade 0 in 0% of the 
patients . After the 7days of Shirodara Grade 3 was 
not seen in any of the patients. Grade 2 was found in 
15%, Grade 1 was found in 45% and Grade 0 was 
found in 40% of the patients. At 14th day of follow up, 
Grade 3 was seen in 0%, Grade 2 was seen in 5% and 
Grade 1 was seen in 50% and Grade 0 was seen in 
45%. While at 21st day of follow up Grade 3 was seen 
in 0%, Grade 2 was seen in 0%, Grade 1 was seen  in 
60% and Grade 0 was seen in 40%. 





















8 (40%) 40.0% 
1 7 (35%) 9 10 12 25.0% 
(45%) (50%) (60%) 




0 (0%) -45.0% 
3 4 (20%) 0 (0%) 0 
(0%) 
0 (0%) -20.0% 
n=20, Group B: Improvement of 65.0% at 0&1 grade is significant 
with P=0.003**, paired Proportion test 
Effects of Nasya on Phonophobia 
Before treatment the number of patients having 
Grade 3 of Phonophobia was seen in 15%, Grade 2 in 
40%, Grade 1 in 45% and Grade 0 in 0% of the 
patients. After the 7days of Nasya, Grade 3 was seen 
in non of the patients. Grade 2 was found in 10%, 
Grade 1 was found in 20% and Grade 0 was found in 
70% of the patients. At 14th day of follow up, Grade 3 
was seen in 0%, Grade 2 was seen in 0% and Grade 1 
was seen in 30% and Grade 0 was seen in 70%. While 
at 21st day of follow up Grade 3 was seen in 0%, Grade 
2 was seen in 0%, Grade 1was seen in 45% and Grade 
0 was seen in 55%. 































2 8 (40%) 2 
(10%) 
0 (0%) 0 (0%) -40.0% 
3 3 (15%) 0 (0%) 0 (0%) 0 (0%) -15.0% 
n=20, Group A: Improvement of 55% at 0 grade is significant with 
P=0.0003**, paired Proportion test 
Effects of Shirodhara on Phonophobia 
Before treatment the number of patients having 
Grade 3 of Photophobia was 15%, Grade 2 was seen in 
45%, Grade 1 in 40% and Grade 0 in 0% of the 
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patients. After the 7days of Shirodara Grade 3 was not 
seen in any of the patients. Grade 2 was found in 20%, 
Grade 1 was found in 40% and Grade 0 was found in 
40% of the patients. At 14th day of follow up, Grade 3 
was seen in 0%, Grade 2 was seen in10% and Grade 1 
was seen in 40% and Grade 0 was seen in 50%. While 
at 21st day of follow up Grade 3 was seen in 0%, Grade 
2 was seen in 5%, Grade 1 was seen in 60% and Grade 
0 was seen in 35%. 





















1 8 (40%) 8 (40%) 8 (40%) 12 
(60%) 
20.0% 
2 9 (45%) 4 (20%) 2 (10%) 1 (5%) -40.0% 
3 3 (15%) 0 (0%) 0 (0%) 0 (0%) -15.0% 
n=20, Group  B:  Improvement  of  55%  at 0 & 1 grade is 
significant with P=0.0135*, paired Proportion test 
DISCUSSION 
Ardhavabhedaka is a Shiroroga which is occurring due 
to Nidanas like Rathri Jagarana, Manahsanthapa, 
Adhyasana, Anasana leading to severe breaking type 
of pain in half of the head associated with other 
features. Based on the etiology and symptoms 
Ardhavabhedaka can be correlated to migraine. 
Migraine is one of the most common as well as painful 
of the chronic pain disorders of head. 
Intensity of pain 
The result of Intensity of pain (Teevratha of Vedana) 
in both group showing statistically significant result 
individually which indicates both the group A & B are 
effective. 
Percentage wise relief of symptom in Group A (85%) is 
better than Group B (70%). 
Nidanas of Ardhavabedhaka show that there will be 
vitiation of Tridoshas. The constituents used in the 
Taila are Tridosha Shamakas and there by relives pain. 
Serotonin uptake inhibitor helps to bring serotonin to 
the synapses. Thereby maintains regular contraction 
of blood vessels and proper neurological transmission 
is maintained. 
Duration of Pain 
The result on Duration of pain (Vedana Pravritti Kala) 
in Group A is showing statistically significant effect of 
50% which indicates group A has better effects than 
Group B (30%). 
As the drug is directly acting on the Shiras by the 
Nasyakarma, the local effect is attained there by the 
duration of pain is decreased. Bioavailability of the 
drug enhanced by lipid media which is proven to cross 
Blood Brain Barrier producing a sustained action of 
the drug. Hence the reduced duration is seen in Group 
A. 
Frequency of the attack 
The result of Frequency of attack in Group A is 
showing statistically significant effect of 45% which 
indicates group A has better effects than Group B 
(35%). 
The Snigdha and Jeevaneeya action of the drug 
imparts the Sthirathwam and thereby the frequency is 
decreased to some extent in both the groups. 
Effect on Nausea and Vomiting 
The result  of  Nausea in  Group  A  is showing 
statistically significant effect of 80% which indicates 
group A has better effects than Group B (50%). 
The result of vomiting in both group showing 
statistically significant result individually which 
indicates both the group A & B are effective. 
Percentage wise relief of symptom in Group A (45%) is 
better than Group B (40%). 
Shiras is the seat of Pranavayu. When Pitta Dosha 
does the Avarana of this Pranavata there will be 
vomiting. The same pathology might have occurred 
here also. Nasya Karma with Ghritha processed with 
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Nirgundi may have corrected the Avarana. Once the 
pain is subsided by the proper transmission of 
neurological impulses, the hyper excited sympathetic 
nerves might have become normal and thus the 
nauseacontrolled. 
Photophobia 
The result on Photophobia in both group showing 
statistically significant results equally i.e. percentage 
improvemwnt in both the Groups A & B is 65% which 
indicates both the group A  & B are equally effective. 
This may have occurred due to the Vataprakopa and 
Rasa Dusti. So Prapaunadarikadi Taila used for 
treatment may have brought shamana to the 
Prakupitavata. 
Phonophobi 
The result on Photophobia in both group showing 
statistically significant results equally i.e. percentage 
improvement in both the Groups A & B is 55% which 
indicates both the group A  & B are equally effective. 
This may have occurred due to the Vataprakopa and 
Rasa Dusti. So Prapaunadarikadi Taila used for 
treatment may have brought Shamana to the 
Prakupitavata. 
Probable mode of action of Nasya Karma 
Penetration of blood brain barrier: Intra nasal 
delivery provides a practical, non invasive method of 
by passing the blood brain barrier (BBB) to deliver 
therapeutic agents to the brain and spinal chord. This 
is possible because of the unique connections that the 
olfactory and trigeminal nerves provide between the 
brain and external environment.[6] 
Reaches brain in < 10 minutes: Extra cellular delivery, 
rather than axonal transport, is strongly indicated by 
the short time frame < 10 minute observed for intra 
nasal therapeutics to reach the brain from the nasal 
mucosa. Possible mechanism of transport may involve 
bulk flow and diffusion within perineural channels, 
perivascular spaces or lymphatic channels directly 
connected to brain tissues or cerebrospinal fluid.[7] 
Lipophilic substances cross BBB: There is a good 
correlation between the lipid solubility of a drug and 
the blood brain barrier penetration in humans. The 
Lipophilic pathways also provides a large surface area 
for drug delivery. These tight endothelium junctions 
of BBB can be 100 times tighter than the junctions of 
other capillary endothelium. Thus, the barrier has 
many properties similar to a continuous cell 
membrane, allowing lipid soluble molecules transport 
across the membrane where hydrophilic solutes 
demonstrate minimal permeation.[8] 
Increased bio availability: Intra nasal route 
administration , bio availability is usually higher than 
orally. This bio availability occurs due to the quick 
absorption of molecules into the blood stream 
through the soft tissues in the mucus membrane of 
the sinus cavity. 
Constituents of Prapaundarikadi Taila having the 
properties of Tridoshahara and also it is having 
properties like Indriya Balavridhikara, Rasayana and 
indicated for Nasya in Shiroroga.[9] 
Discussion on Shirodhara 
In the treatment of Vatika Shirahshoola, Acharya 
Sushruta and Vagbhata have mentioned Shirodhara, 
Ardhavabheka is Shoola Pradhana Vyadi and there 
will be involvement of Vata Dosha predominantely. 
Shirodhara is a safe and effective, treatment, hence it 
was selected for the study. It was also selected to 
evaluate whether the procedural effect or the 
therapeutic effect of the medicament is acting in this 
disease. 
Probable mode of action of Shirodhara 
Shirodhara is effective in following two ways; 
1. Therapeutic effect of medicaments 
2. Procedural effect of the process 
Therapeutic effect of medicament 
The therapeutic effect is partially attributed to the 
medicaments viz. the medicated oil, Ghrita, butter 
milk, Kwatha etc. which exchange through the fine 
pores present over the scalp and forehead. As it is 
said by Acharya Susrutha that that the effect and 
potencies of the articles of Abhyanga, Parisheka, 
Udvartana, etc. which are digested by the skin, enter 
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into the Shareera through the orifices present in the 
skin. The modern physiology and biochemistry say 
that it is possible to produce a certain amount of 
absorption by the application of substances conveyed 
in fatty vehicles. 
PROCEDURAL EFFECT 
Stimulatory Effect 
Bhrumadhya is the area which corresponds to that 
external anatomy over the forehead, which is 
concerned with the fundamental endocrine glands 
like the Pineal and Pituitary gland. In Shirodhara, 
potential energy of medicament is propagated and 
converted to mechanical waves to forehead. It then 
passes to mid brain where pineal gland lies and 
stimulates the secretion of Seratonin whose absence 
produces the disease. 
Also the nerve endings of Opthalmic branch of 
trigeminal, facial and dermatomes are arranged over 
surface of frontal skin and forehead gets stimulated 
during Dhara Chikitsa and impulse is transmitted to 
CNS which results in the subsistence of tension, 
neuralgia and vascular headache. 
Regulatory effect 
Action of Dhara also mediates through tactile and 
thermo receptive sensations. Shirodhara induce 
tactile stimulation over forehead and may activate 
supra chiasmatic nuclei located in Hypothalamus and 
regulates the Circadian Rhythm. 
Thermal effect 
Warm liquid used for Dhara stimulate efferent 
vasodilator nerve and causes peripheral 
vasodilatation and results in increase of filtration co-
efficient & lipid water co-efficient of drug. 
Pressure effect 
If prolonged pressure is applied to a nerve impulse 
conduction by that nerve is interrupted & part of body 
may go to sleep. In Dhara Chikitsa, prolonged and 
continuous pressure produced due to trickling of 
medicated liquid cause tranquility of mind and 
induces natural sleep. 
Massage effect 
Gentle massage over forehead, improves circulation 
to head relaxes the muscles and nerve endings. It 
increase fresh O2 & glucose supply to brain and 
increase CSF circulation around brain & spinal cord. It 
also increases release of hormones & enzymes by 
stimulating pineal & pituitary gland. 
Nasya being a Shodhana Karma eliminates the morbid 
Dosha of Urdhwa Jatru and expels them from the 
uttamanga and nutritive part of Nasya is nourishes 
the Shirah (head). 
Shirodhara where in continuous pouring of 
Prapaundarikadi Taila in relaxed and comfortable 
position has sedative and soothing effect to the brain. 
Also the Taila enters into the circulation does the 
Tridoshashamana. 
Thus over all both therapies pacifie Vata, Vata Kapha 
or Tridosa and hence does the Samprapti Vighatana 
of Ardhavabhedaka. 
CONCLUSION 
The study showed significant results for both 
treatments, Nasya and Shirodhara with 
Prapaundarikadi Taila in Ardhavabhedaka. Both the 
treatments, Nasya and Shirodhara had long term 
effects in Ardhavabhedaka as the symptoms were 
found to reduce even during the follow up periods. 
Group treated with Shirodhara showed a significant 
reduction of symptoms by the 7th day and later even 
though reduction was seen, much difference was not 
appreciated (more of instant effect). While in the 
group treated with Nasya, relief of all the signs & 
symptoms was not predominant on the 7th day, but 
results were found better during the follow up period 
(more of long term effect). It was also found that 
there was statistically significant result seen in both 
the groups while comparing the symptoms before and 
after the treatments. However, the results obtained 
for Nasya on clinical side was encouraging when 
compared to Shirodhara. But on applying the test of 
significance no difference could be made out between 
the two procedures. 
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